×

Pharmaceutical formulation comprising levothyroxine sodium

  • US 7,955,621 B2
  • Filed: 07/08/2004
  • Issued: 06/07/2011
  • Est. Priority Date: 07/10/2003
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical formulation in unit dose form which is a “

  • 50 μ

    g tablet”

    of active ingredient comprising;

    0.0425-0.0575 mg levothyroxine sodium, 50-60 mg microcrystalline cellulose which has a mean particle size of less than 125 μ

    m, 12-17 mg pregelatinised starch which is produced by subjecting moistened starch to mechanical pressure in order to rupture some or all of its starch granules and subsequent drying, 2-3 mg talc, 1-2 mg colloidal anhydrous silica, and 0.5-1.0 mg magnesium stearate.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×